Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

NCT00114959 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Poor enrollment

Conditions

Myeloid Leukemia, Chronic
Myeloid Leukemia, Chronic, Accelerated-Phase
Blast Phase
Myeloid Leukemia, Chronic, Chronic-Phase

Interventions

DRUG: Homoharringtonine
DRUG: Imatinib Mesylate

Sponsor

ChemGenex Pharmaceuticals